mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.7 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.7 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |